Neil W. DeLapp

1.8k total citations
44 papers, 1.4k citations indexed

About

Neil W. DeLapp is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Neil W. DeLapp has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 26 papers in Cellular and Molecular Neuroscience and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Neil W. DeLapp's work include Receptor Mechanisms and Signaling (28 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neuropeptides and Animal Physiology (11 papers). Neil W. DeLapp is often cited by papers focused on Receptor Mechanisms and Signaling (28 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neuropeptides and Animal Physiology (11 papers). Neil W. DeLapp collaborates with scholars based in United States, Denmark and United Kingdom. Neil W. DeLapp's co-authors include Frank P. Bymaster, John S. Ward, Christian C. Felder, Harlan E. Shannon, Per Sauerberg, Malcolm J. Sheardown, Julie F. Falcone, Michael D.B. Swedberg, Anders Fink‐Jensen and David O. Calligaro and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and Pain.

In The Last Decade

Neil W. DeLapp

44 papers receiving 1.4k citations

Peers

Countries citing papers authored by Neil W. DeLapp

Since Specialization

Citations

This map shows the geographic impact of Neil W. DeLapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil W. DeLapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil W. DeLapp more than expected).

Fields of papers citing papers by Neil W. DeLapp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil W. DeLapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil W. DeLapp. The network helps show where Neil W. DeLapp may publish in the future.

Co-authorship network of co-authors of Neil W. DeLapp

This figure shows the co-authorship network connecting the top 25 collaborators of Neil W. DeLapp. A scholar is included among the top collaborators of Neil W. DeLapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil W. DeLapp. Neil W. DeLapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multiple dopamine receptors mediate the discriminative stimulus effects of dihydrexidine in rats 2011 ·Behavioural Pharmacology ·Scott D. Gleason, Tinggui Yin, Sheila P. Little, Neil W. DeLapp, Jeffrey M. Witkin	1
2	Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats 2010 ·The International Journal of Neuropsychopharmacology ·Jørn Arnt, Benny Bang‐Andersen, Ben Grayson, F.P. Bymaster, Michael P. Cohen, Neil W. DeLapp, (unknown), Mads Kreilgaard, David L. McKinzie, Joanna C. Neill, David L. Nelson, Søren Nielsen, (unknown), John M. Schaus, Louise Witten	92
3	The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies 2006 ·SLAS DISCOVERY ·Brian J. Eastwood, Mark W. Farmen, Philip W. Iversen, Trelia J. Craft, Jeffrey K. Smallwood, (unknown), Neil W. DeLapp, Gerald F. Smith	100
4	Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine 2001 ·European Journal of Pharmacology ·Frank P. Bymaster, Julie F. Falcone, (unknown), John Kennedy, Kathryn W. Schenck, Neil W. DeLapp, Marlene L. Cohen	103
5	Receptor reserve of phosphoinositide-coupled muscarinic receptors in mouse hippocampus in vivo 2001 ·Brain Research ·(unknown), (unknown), Neil W. DeLapp, David O. Calligaro, Christian C. Felder	6
6	The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance 2001 ·Schizophrenia Research ·Thøger Rasmussen, Anders Fink‐Jensen, Per Sauerberg, Michael D.B. Swedberg, Christian Thomsen, Malcolm J. Sheardown, Lone Jeppesen, David O. Calligaro, Neil W. DeLapp, Celia A. Whitesitt, John S. Ward, (unknown), Frank P. Bymaster	31
7	Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice 2000 ·European Journal of Pharmacology ·Thøger Rasmussen, Per Sauerberg, Erik B. Nielsen, Michael D.B. Swedberg, C. Thomsen, Malcolm J. Sheardown, Lone Jeppesen, David O. Calligaro, Neil W. DeLapp, Celia A. Whitesitt, John S. Ward, Harlan E. Shannon, (unknown), Anders Fink‐Jensen	33
8	Potential role of muscarinic receptors in schizophrenia 1999 ·Life Sciences ·Frank P. Bymaster, Harlan E. Shannon, Kurt Rasmussen, Neil W. DeLapp, John S. Ward, David O. Calligaro, Charles H. Mitch, Celia A. Whitesitt, (unknown), Malcolm J. Sheardown, Michael D.B. Swedberg, Thøger Rasmussen, Preben H. Olesen, Lone Jeppesen, Per Sauerberg, Anders Fink‐Jensen	46
9	Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane 1998 ·European Journal of Pharmacology ·(unknown), Harlan E. Shannon, Kurt Rasmussen, Neil W. DeLapp, Charles H. Mitch, John S. Ward, David O. Calligaro, (unknown), Malcolm J. Sheardown, Preben H. Olesen, Michael D.B. Swedberg, Per Sauerberg, Anders Fink‐Jensen	53
10	Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects 1998 ·Brain Research ·Frank P. Bymaster, (unknown), Steven Peters, Wei Zhang, John S. Ward, Charles H. Mitch, David O. Calligaro, Celia A. Whitesitt, Neil W. DeLapp, Harlan E. Shannon, Karin Rimvall, Lone Jeppesen, Malcolm J. Sheardown, Anders Fink‐Jensen, Per Sauerberg	56
11	Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned rats 1998 ·Neuroreport ·Anders Fink‐Jensen, Peter Lommer Kristensen, Harlan E. Shannon, David O. Calligaro, Neil W. DeLapp, (unknown), John S. Ward, C. Thomsen, (unknown), Malcolm J. Sheardown, Lone Jeppesen, Per Sauerberg, Frank P. Bymaster	22
12	Effects of the M1 Agonist Xanomeline on Processing of Human β-Amyloid Precursor Protein (FAD, Swedish Mutant) Transfected into Chinese Hamster Ovary-m1 Cells 1998 ·Biochemical and Biophysical Research Communications ·Neil W. DeLapp, Su Wu, Rama M. Belagaje, Edward Johnstone, (unknown), Harlan E. Shannon, Frank P. Bymaster, David O. Calligaro, Charles H. Mitch, Celia A. Whitesitt, John S. Ward, Malcolm J. Sheardown, Anders Fink‐Jensen, Lone Jeppesen, Christian Thomsen, Per Sauerberg	27
13	Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic M1 receptor activation 1998 ·Bioorganic & Medicinal Chemistry Letters ·Per Sauerberg, Lone Jeppesen, Preben H. Olesen, Malcolm J. Sheardown, Anders Fink‐Jensen, Thøger Rasmussen, Karin Rimvall, Harlan E. Shannon, Frank P. Bymaster, Neil W. DeLapp, (unknown), John S. Ward, Celia A. Whitesitt, C. Thomsen	7
14	Pharmacology of Butylthio[2.2.2] (LY297802/NNC11-1053): A Novel Analgesic with Mixed Muscarinic Receptor Agonist and Antagonist Activity 1997 ·Journal of Pharmacology and Experimental Therapeutics ·Harlan E. Shannon, Malcolm J. Sheardown, Frank P. Bymaster, David O. Calligaro, Neil W. DeLapp, J. S. Gidda, (unknown), Barry D. Sawyer, Peter W. Stengel, John S. Ward, David T. Wong, Preben H. Olesen, Peter D. Suzdak, Per Sauerberg, Michael D.B. Swedberg	22
15	Intrathecal pertussis toxin produces hyperalgesia and allodynia in mice 1997 ·Pain ·(unknown), Neil W. DeLapp, (unknown)	47
16	Muscarinic agonist inhibition of rat striatal adenylate cyclase is enhanced by dopamine stimulation 1996 ·Life Sciences ·Neil W. DeLapp, (unknown), Harlan E. Shannon	9
17	The M1 agonist xanomeline potently stimulates APPs release from CHO-m1 cells 1995 ·Life Sciences ·Neil W. DeLapp, (unknown), Frank P. Bymaster, (unknown), (unknown), John S. Ward	1
18	The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from chinese hamster ovary-m1 cells 1995 ·Life Sciences ·(unknown), Frank P. Bymaster, (unknown), Harlan E. Shannon, John S. Ward, Neil W. DeLapp	44
19	Forskolin Stimulation of Cyclic AMP Accumulation in Rat Brain Cortex Slices Is Markedly Enhanced by Endogenous Adenosine 1992 ·Journal of Neurochemistry ·Neil W. DeLapp, (unknown)	23
20	Effect of Basic Fibroblast Growth Factor (bFGF) and Insulin-Like Growth Factors Type I (IGF-I) and Type II (IGF-II) on Adult Human Keratinocyte Growth and Fibronectin Secretion 1990 ·Journal of Investigative Dermatology ·Neil W. DeLapp, (unknown)	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact